# Kiora Pharmaceuticals, Inc. (KPRX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/KPRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -2.42M | $ -3.17M | $ 373.6K | $ 13.93M |
| 2025 | $ 0 | $ -11.09M | $ -10.31M | $ 368.3K | $ 16.13M |
| 2024 | $ 16.82M | $ 3.78M | $ 8.99M | $ 57.2K | $ 25.76M |
| 2023 | $ 0 | $ -13.53M | $ -10.33M | $ 106.9K | $ 6.11M |
| 2022 | $ 0 | $ -15.17M | $ -11.65M | $ 105.8K | $ 11.41M |
| 2021 | $ 0 | $ -15.86M | $ -13.10M | $ 209.4K | $ 14.58M |
| 2020 | $ 15.4K | $ -8.74M | $ -9.35M | $ 574.4K | $ 9.73M |
| 2019 | $ 3.47M | $ -9.16M | $ -10.52M | $ 83.9K | $ 6.62M |
| 2018 | $ 2.18M | $ -14.28M | $ -14.38M | $ 4.7K | $ 8.94M |
| 2017 | $ 549.0K | $ -17.81M | $ -8.76M | $ 16.1K | $ -1.93M |
| 2016 | $ 920.8K | $ -18.36M | $ -11.61M | $ 28.7K | $ -329.4K |
| 2015 | $ 0 | $ -11.78M | $ -6.26M | $ 0 | $ 6.09M |
| 2014 | $ 0 | $ -2.51M | $ -1.34M | $ 3.21M | $ -46.81M |
| 2013 | $ 0 | $ -5.52M | $ -4.21M | $ 2.03M | $ -44.84M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.03 |
| Liabilities / Eq | 0.52 |
| Current Ratio | 6.68 |

## Other views

- [Metrics](https://sponda.capital/en/KPRX.md)
- [Charts](https://sponda.capital/en/KPRX/charts.md)
- [Compare](https://sponda.capital/en/KPRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.